Reentrant tachycardias. A look at where treatment stands today. 1998

B J Karas, and B P Grubb
Department of Medicine, Medical College of Ohio, Toledo 43699-0008, USA.

Cardiac dysfunction is not limited to the elderly. In fact, the forms of tachycardia discussed in this article usually begin before age 40. The authors summarize the mechanisms involved and the findings on electrocardiography that help identify the type of dysrhythmia in patients presenting with palpitations and other signs of possible cardiac disease. In addition, they describe the procedure that has revolutionized treatment for reentrant tachycardia: closed-chest radiofrequency catheter ablation.

UI MeSH Term Description Entries
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D013611 Tachycardia, Atrioventricular Nodal Reentry Abnormally rapid heartbeats caused by reentry of atrial impulse into the dual (fast and slow) pathways of ATRIOVENTRICULAR NODE. The common type involves a blocked atrial impulse in the slow pathway which reenters the fast pathway in a retrograde direction and simultaneously conducts to the atria and the ventricles leading to rapid HEART RATE of 150-250 beats per minute. Atrioventricular Nodal Re-Entrant Tachycardia,Atrioventricular Nodal Reentry Tachycardia,Atrioventricular Reentrant Tachycardia,Tachycardia, AV Nodal Reentrant,AV Nodal Reentrant Tachycardia,Atrioventricular Nodal Reentrant Tachycardia,Atrioventricular Nodal Re Entrant Tachycardia,Atrioventricular Reentrant Tachycardias,Reentrant Tachycardia, Atrioventricular,Tachycardia, Atrioventricular Reentrant
D017115 Catheter Ablation Removal of tissue with electrical current delivered via electrodes positioned at the distal end of a catheter. Energy sources are commonly direct current (DC-shock) or alternating current at radiofrequencies (usually 750 kHz). The technique is used most often to ablate the AV junction and/or accessory pathways in order to interrupt AV conduction and produce AV block in the treatment of various tachyarrhythmias. Ablation, Transvenous Electric,Catheter Ablation, Electric,Catheter Ablation, Percutaneous,Catheter Ablation, Radiofrequency,Catheter Ablation, Transvenous,Ablation, Catheter,Ablation, Transvenous Electrical,Catheter Ablation, Electrical,Electric Catheter Ablation,Electrical Catheter Ablation,Percutaneous Catheter Ablation,Radiofrequency Catheter Ablation,Transvenous Catheter Ablation,Ablation, Electric Catheter,Ablation, Electrical Catheter,Ablation, Percutaneous Catheter,Ablation, Radiofrequency Catheter,Ablation, Transvenous Catheter,Electric Ablation, Transvenous,Electrical Ablation, Transvenous,Transvenous Electric Ablation,Transvenous Electrical Ablation

Related Publications

B J Karas, and B P Grubb
March 1973, The New York state dental journal,
B J Karas, and B P Grubb
June 1970, RN,
B J Karas, and B P Grubb
May 1978, The Journal of bone and joint surgery. British volume,
B J Karas, and B P Grubb
March 2010, Expert opinion on drug metabolism & toxicology,
B J Karas, and B P Grubb
January 2009, Hormones (Athens, Greece),
B J Karas, and B P Grubb
January 1958, Transactions. Ophthalmological Society of the United Kingdom,
B J Karas, and B P Grubb
January 1980, Indian heart journal: teaching series,
B J Karas, and B P Grubb
December 2019, Seminars in interventional radiology,
B J Karas, and B P Grubb
March 1973, RN,
B J Karas, and B P Grubb
December 1990, Pacing and clinical electrophysiology : PACE,
Copied contents to your clipboard!